Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Hba1c Article
This is a selection made from among articles on Drug Treatment Hba1c. For a permanent link to this article, or to bookmark it for future reading, click here.
Effects of Drug Addiction
from:The effects of drug addiction are far reaching and go way beyond just affecting the life of the addict. Drug addiction has an effect on families, companies, schools, and friendships. It also has an effect on the body of the addict and could possibly affect the health of those around the addict.
People who use drugs experience a wide array of physical effects other than those expected. The excitement of a cocaine high, for instance, is followed by a “crash”: a period of anxiety, fatigue, depression, and an acute desire for more cocaine to alleviate the feelings of the crash. Marijuana and alcohol interfere with motor control and are factors in many automobile accidents. Users of marijuana and hallucinogenic drugs may experience flashbacks, unwanted recurrences of the drug's effects weeks or months after use.
Sharing hypodermic needles leads to an increased risk of HIV and some forms of hepatitis. That, along with increased sexual activity among drug addicts can greatly increase the incidence of people becoming infected with AIDS and sexually transmitted diseases.
There are over 10,000 deaths directly attributable to drug use in the United States every year; the substances most frequently involved are cocaine, heroin, and morphine, often combined with alcohol or other drugs. Many drug users engage in criminal activity, such as burglary and prostitution, to raise the money to buy drugs, and some drugs, especially alcohol, are associated with violent behavior.
The user's preoccupation with the substance, plus its effects on mood and performance, can lead to marital problems and poor work performance or dismissal. Drug use can disrupt family life and create destructive patterns of codependency, that is, the spouse or whole family, out of love or fear of consequences, inadvertently enables the user to continue using drugs by covering up, supplying money, or denying there is a problem.
Pregnant drug users, because of the drugs themselves or poor self-care in general, bear a much higher rate of low birth-weight babies than the average. Many drugs (e.g., crack and heroin) cross the placental barrier, resulting in addicted babies who go through withdrawal soon after birth, and fetal alcohol syndrome can affect children of mothers who consume alcohol during pregnancy. Pregnant women who acquire the AIDS virus through intravenous drug use pass the virus to their infant.
Drug abuse affects society in many ways. In the workplace it is costly in terms of lost work time and inefficiency. Drug users are more likely than nonusers to have occupational accidents, endangering themselves and those around them. Over half of the highway deaths in the United States involve alcohol.
Drug-related crime can disrupt neighborhoods due to violence among drug dealers, threats to residents, and the crimes of the addicts themselves. In some neighborhoods, younger children are recruited as lookouts and helpers because of the lighter sentences given to juvenile offenders, and guns have become commonplace among children and adolescents. The great majority of homeless people have either a drug or alcohol problem or a mental illness—many have all three.
Drug addiction has an effect on all parts of life for the drug user, the family, and society as a whole. The time to get help for an addiction is NOW before its effects become so far-reaching, they cannot be recovered.
Drug Treatment Hba1c Specific links
Drug Treatment Hba1c News
Eli Lilly's diabetes drug meets mid-stage trial goal
(Reuters) - Drugmaker Eli Lilly and Co's experimental drug to treat type 2 diabetes met the main goal of a mid-stage trial to test its effect on blood pressure and heart rate. The results of the study showed that the effect of Lilly's drug, dulaglutide, on systolic blood pressure was comparable to that of a placebo. Makers of type 2 diabetes pills are required by the U.S. health regulator to ...
Read more...Jentaduetoâ„¢ (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of adults with ...
INGELHEIM, Germany--(BUSINESSWIRE)-- Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a positive opinion from the European Medicines Agency’s (EMA) medicinal committee ...
Read more...New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African American patients with type 2 diabetes ...
RIDGEFIELD, Conn. and INDIANAPOLIS, May 24, 2012 /PRNewswire/ --Â Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced Phase 3 study results for linagliptin 5 ...
Read more...Linagliptin safe and effective for African American patients with type 2 diabetes
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Phase 3 study results for linagliptin 5 mg once-daily, which showed significant hemoglobin A1c (HbA1c or A1C) reduction of 0.88 percent compared to 0.24 percent in the placebo group (p=0.0002) at 24 weeks in black or African American adult patients with type 2 diabetes whose blood sugar was not adequately ...
Read more...Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of ...
Baxter International Inc. today announced results from two large, international multicenter trials demonstrating that a low glucose peritoneal dialysis regimen favorably impacted metabolic measures important for end-stage renal disease patients with diabetes, including blood glucose control and selected lipids .
Read more...FDA Approves Levemir® for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
PRINCETON, N.J., May 22, 2012 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has approved Levemir ® (insulin detemir [rDNA ...
Read more...BUSINESS WIRE: JentaduetoTM (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of ...
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.
Read more...BUSINESS WIRE: Jentaduetoâ„¢ (linagliptin/metformin hydrochloride) tablets recommended for approval in the treatment of ...
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.Upon approval, new treatment will provide a single tablet option for adults who need to improve their blood sugar controlFor Non-U.S. and Non-UK MediaINGELHEIM, Germany --(BUSINESS WIRE)-- 25.05.2012 --Boehringer...
Read more...Press Release
Boehringer Ingelheim and Eli Lilly and Company today announced that they have received a positive opinion from the European Medicines Agency’s (EMA) medicinal committee recommending approval of Jentadueto™, which combines the DPP-4 inhibitor, linagliptin (the active ingredient in Trajenta® tablets) and metformin in a single tablet . 1 If approved by the European Commission, linagliptin/metformin ...
Read more...Persistent Concerns About Lorcaserin (Lorqess) From FDA Reviewers
The FDA has posted??briefing documents??for Thursday?s meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to reconsider the new drug application for lorcaserin (Lorqess, Arena). The same panel recommended against approval of the drug in September 2010, citing weak efficacy and safety concerns. The FDA reviewers do not appear to have substantially altered their view ...
Read more...